Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series
Lalit Verma ,1 Mithun Thulasidas ,1 Avnindra Gupta 1 1 Centre for Sight, Delhi 110029, IndiaCorrespondence: Lalit Verma; Mithun ThulasidasCentre for Sight, B-5/24, Safdarjung Enclave, Delhi 110029, IndiaEmail lalitverma@yahoo.com; mithun.thulasidas@gmail.comPurpose: To report a case series of four...
Main Authors: | Verma L, Thulasidas M, Gupta A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/intravitreal-clindamycin-as-first-line-therapy-for-toxoplasmic-retinoc-peer-reviewed-article-OPTH |
Similar Items
-
Foveal reorganization after treatment of acute foveal toxoplasmic retinochoroiditis
by: Mojtaba Abrishami, et al.
Published: (2021-06-01) -
Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis
by: Rodrigo Jorge, MD, PhD, et al.
Published: (2021-06-01) -
A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis
by: Alireza Lashay, et al.
Published: (2017-06-01) -
Spontaneous closure of macular hole in a case of toxoplasma retinochoroiditis
by: Shreyansh Doshi, et al.
Published: (2020-01-01) -
Treatment of toxoplasmic encephalitis with the combination of clindamycin plus azithromycin in an HIV‐infected patient: A case report
by: Keyhan Mohammadi, et al.
Published: (2021-05-01)